Pharmaceutical - Cardio-vascular, Inflammatory diseases


Popular Filters

AstraZeneca plans more job cuts; inks $240M-plus deal with Moderna; expands alliance with Karolinska Institutet


Anglo-Swedish drug major AstraZeneca (LSE: AZN), ahead of its Investor Day briefing in New York later…

AstraZenecaCardio-vascularFinancialImmunologicalsInflammatory diseasesLicensingModerna TherapeuticsOncologyPharmaceuticalResearch

BioLineRx inks deal with Compugen


Israeli biopharma company BioLineRx (TASE: BLRX) has entered into a collaboration with fellow Israel-based…

BioLineRxBiotechnologyCardio-vascularCompugenInflammatory diseasesLicensingOncologyPharmaceuticalResearch

Compugen links with DiscoveRx on novel peptide ligands for GPCR drug targets


Israel’s Compugen (Nasdaq: CGEN) and USA-based DiscoveRx have entered into a partnership for the…

Cardio-vascularCompugenDiscoveRxInflammatory diseasesPharmaceuticalResearch

Back to top